Myricx Pharma: Funding, Investors & Team (Sep 2026)
Myricx Pharma is a small molecule drug discovery company engaged in developing novel proprietary inhibitors of human N-myristoyltransferases (NMT), with a primary focus in oncology but also exploring potential applications across other diseases.
Myricx Pharma has raised $4.5M across 1 funding round on record, the most recent an undisclosed round of $4.5M announced in Nov 2020.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Myricx Pharma Company Profile and Key Stats
Latest funding round on record: Nov 2020.
Myricx Pharma Funding Rounds
Myricx Pharma Founders and Leadership Team
No contact details are on record for this team yet.
Myricx Pharma Funding Compared to Other Biotechnology Startups
Myricx Pharma's latest round of $4.5M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Myricx Pharma in Biotechnology and Stevenage
Companies Similar to Myricx Pharma
Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of…
Biodexa Pharmaceuticals is an international specialty pharmaceutical company focused on oncology and other…
Concert Bio helps businesses create optimal microbial communities.
RQ Bio is a biotechnology company that develops long-acting monoclonal antibodies against seasonal influenza…
N4 Pharma is a drug reformulation company focused on developing and out licensing new versions of existing…
Laverock Therapeutics is working on developing a system for suppressing genes, which can be used to create…
Oak hill bio is a clinical-stage rare disease therapeutics company developing life-changing medicines.
IMU is a discovery engine mapping the immune system to advance precision medicine.
Mykor is a climate tech start-up. It decarbonizes the construction industry by manufacturing carbon-negative…
Neurovalens provides cutting-edge solutions in the realms of neuroscience, bioscience, and neurophysiology.…
Voxmind's biometric confirmation and authentication platform that provides voice based biometrics that helps…
Five is a biometric payment services company that offers thumb recognition technology for safe transactions.
Myricx Pharma Funding FAQs
What does Myricx Pharma do?
Myricx Pharma is a small molecule drug discovery company engaged in developing novel proprietary inhibitors of human N-myristoyltransferases (NMT), with a primary focus in oncology but also exploring potential applications across other diseases.
How much funding has Myricx Pharma raised?
Myricx Pharma has raised $4.5M across 1 round on record. The most recent is an undisclosed round of $4.5M announced in Nov 2020.
When did Myricx Pharma last raise funding?
Myricx Pharma's most recent funding round on record is an undisclosed round of $4.5M, announced in Nov 2020.
Who is the CEO of Myricx Pharma?
Roberto Solari is listed as CEO at Myricx Pharma.
Where is Myricx Pharma headquartered?
Myricx Pharma is based in Stevenage, Herefordshire, United Kingdom.
How many employees does Myricx Pharma have?
Myricx Pharma is in the 1-10 employee band.
How does Myricx Pharma's funding compare to other Biotechnology startups?
Myricx Pharma's latest round of $4.5M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Myricx Pharma Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Myricx Pharma is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.